Skip to content

    GPT Healthcare

    GPTHEALTH
    Healthcare·24 May 2025
    Management Summary

    GPT Healthcare reported a mixed Q4 and FY25, with full-year PAT growing 5% to INR 50 crores and achieving net debt-free status. The company expanded its bed capacity to 719 with the commissioning of a 158-bed facility in Raipur and signed an MoU for a 150-bed hospital in Jamshedpur, moving closer to its 1,000-bed target. However, revenue growth was modest at 2% in Q4, and full-year EBITDA saw a slight dip due to new hospital-related expenses and external factors impacting volumes.

    Highlights

    5
    • Full Year PAT grew 5% YoY to INR 50 crores.

    • Became a net debt-free company, driven by a 55% YoY decline in finance costs.

    • Commissioned a 158-bed facility in Raipur, expanding total bed capacity to 719.

    • Signed an MoU for a 150-bed hospital in Jamshedpur, moving closer to the 1,000-bed target.

    • Achieved an ROE of 23.5% and a ROCE of 20% for FY25.

    Concerns

    3
    • Q4 FY25 revenue growth was modest at 2% YoY, reaching INR 101 crores.

    • Full Year FY25 EBITDA dipped slightly by 1% to INR 92 crores due to new hospital expenses and higher impairment provisioning.

    • Consolidated volume growth for FY25 was flattish, impacted by external factors like the R.G. Kar incident in Kolkata and Bangladesh-related issues/floods in Tripura.

    What Changed1

    vs Q1 FY26

    Risks discussed5 → 3 (-2)
    Key financials

    Metrics

    15

    Periods

    3

    Headline

    4
    • Average Length of Stay (ALOS)
      3.54 days
    • ARPOB
      ₹37,200
    • Bed Occupancy
      53%
    • Cash & Insurance Patients
      94%

    Q4 FY25

    4
    • Revenue
      ₹101 Cr
      YoY+2%
    • EBITDA
      ₹22 Cr
    • EBITDA Margin
      21.6%
    • PAT
      ₹13 Cr

    FY25

    7
    • Revenue
      ₹407 Cr
    • EBITDA
      ₹92 Cr
      YoY-1%
    • EBITDA Margin
      22%
    • PAT
      ₹50 Cr
      YoY+5%
    • Finance Cost
      YoY-55.0%

    Segment breakdown

    • ILS Hospital Salt Lake39,200 Rs26.7%
    • Agartala Hospital33,700 Rs22.9%
    • Dum Dum Hospital41,000 Rs27.9%
    • Howrah Hospital33,000 Rs22.5%
    Donut· Share of ARPOB (FY25)

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Debt

    Net ₹0 crores · 0.0x EBITDA

    Liquidity

    Liquidity disclosed

    Net debt-free status enhances ability to invest in future growth opportunities with greater flexibility and confidence.

    Guidance & targets

    16
    CategoryTargetPriority
    Capacity
    Total bed count
    1,000 beds
    High
    Capacity
    Jamshedpur hospital commissioning
    High
    Profitability
    Raipur Hospital breakeven
    month-on-month breakeven
    High
    Profitability
    Overall EBITDA margin
    22.5-23%
    Medium
    Volume
    Raipur Hospital occupancy
    ~20%
    High
    Volume
    Dum Dum Hospital occupancy
    72-73%
    High
    Volume
    Salt Lake Hospital occupancy
    70%
    High
    Volume
    Agartala Hospital occupancy
    55%
    High
    Volume
    Howrah Hospital occupancy
    50%
    High
    Revenue
    Raipur Hospital ARPOB matching existing
    High
    Revenue
    Salt Lake Hospital ARPOB growth
    8-10%
    Medium
    Revenue
    Agartala Hospital ARPOB growth
    15%
    Medium
    Revenue
    Dum Dum Hospital ARPOB growth
    7-8%
    Medium
    Revenue
    Howrah Hospital ARPOB growth
    10-12%
    Medium
    Revenue
    Company growth
    15%
    Medium
    Cost
    Cost inflation
    7-8%
    Medium

    Raipur Hospital Occupancy Ramp-up

    next year (FY26)
    Current~0% (just commissioned)
    Target~20% (by end of first year)

    Why it matters

    Key indicator for the successful ramp-up and operational efficiency of the newly commissioned facility.

    We expect that in the first year of operations, we would be stabilizing at around the 20% mark for that hospital.

    How to verify

    guidance_and_targets[metric='Raipur Hospital occupancy']

    Risks & concerns

    3
    RiskSeverity

    External factors impacting volume growth (R.G. Kar incident, Bangladesh issues, floods)

    The R.G. Kar incident in Kolkata affected Dum Dum volumes for 3-4 months, and the Bangladesh issue combined with large-scale floods impacted Agartala volumes for 2-3 months, leading to flattish consolidated volume growth in FY25.Management acknowledged

    medium

    Initial business loss from new Raipur hospital

    The new Raipur hospital is expected to incur a business loss of INR 7-8 crores in the coming financial year, which will impact the overall EBITDA by 5-6%.Management acknowledged

    medium

    Delay in Ranchi project

    The Ranchi project has been delayed due to the developers awaiting necessary clearances, with the company still awaiting updates.Management acknowledged

    low

    Q&A highlights

    6

    “The R. G. Kar incident in Kolkata, which is very, very close to our Dum Dum Hospital really affected the numbers to a large extent in that hospital and Agartala has been greatly affected by the Bangladesh issue, plus large-scale floods, which happened in Tripura.”

    Explains the underperformance in volume growth for the year, attributing it to specific external events rather than internal operational issues.

    asked by Naman Bhansali

    2 min read6 chapters

    Detailed Narrative

    01

    Strategic Expansion and Capacity Addition

    GPT Healthcare commissioned a new 158-bed facility in Raipur on May 2, 2025, operating under an asset-light rental model, bringing the total bed count to 719 across five multi-specialty hospitals. This facility offers advanced care across various specialties including cardiac sciences and oncology. Additionally, the company signed an MoU for a 150-bed hospital in Jamshedpur, with an estimated investment of INR 65 crores, targeting commissioning by Q3 FY27, as part of its goal to reach 1,000 beds.

    02

    Financial Performance and Debt-Free Status

    For Q4 FY25, revenue from operations stood at INR 101 crores, a 2% YoY growth, with an EBITDA of INR 22 crores and a margin of 21.6%. For the full year FY25, revenue was INR 407 crores, and PAT grew 5% YoY to INR 50 crores, achieving a 12% PAT margin. A significant highlight was the 55% YoY decline in finance costs, leading the company to become net debt-free, which strengthens its balance sheet and enhances future growth flexibility.

    03

    Operational Efficiency and ARPOB Growth

    The company improved its average length of stay (ALOS) to 3.54 days from 3.95 days in the prior year, optimizing case mix and enhancing throughput. The average revenue per occupied bed (ARPOB) was INR 37,200, reflecting a focus on the middle to high-income segment, with 94% of business from cash and insurance patients. Hospital-wise, Salt Lake's ARPOB increased 15% to INR 39,200, Agartala's 16% to INR 33,700, Dum Dum's 8% to INR 41,000, and Howrah's to INR 33,000.

    04

    Challenges in Volume Growth and External Factors

    Consolidated volume growth for FY25 was flattish, primarily due to external factors. The R.G. Kar incident in Kolkata significantly impacted volumes at Dum Dum Hospital for 3-4 months. Agartala Hospital was affected by the Bangladesh issue and large-scale floods in Tripura, which hampered connectivity for 2-3 months. Despite these challenges, management expects to regain momentum in the coming year.

    05

    Outlook on Margins, Growth, and Occupancy

    Management expects an overall EBITDA margin of 22.5-23% for the coming financial year, despite an anticipated business loss of INR 7-8 crores from the new Raipur hospital. The company targets a 15% YoY growth, driven by new hospitals and the introduction of new specialties in existing facilities. Occupancy rates for FY26 are projected to stabilize at 72-73% for Dum Dum, 70% for Salt Lake, 55% for Agartala, and 50% for Howrah, with Raipur aiming for 20% in its first year.

    06

    Ranchi Project Delay and Jamshedpur Progress

    The Ranchi project has faced delays due to the developers awaiting necessary clearances, with the company still awaiting updates on this front. In contrast, the Jamshedpur hospital project, for which an MoU was signed, is progressing well, with the G+4 building already constructed and undergoing modifications to meet requirements, reinforcing the company's commitment to expanding its presence in underserved regions.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.